PD-Rx Pharmaceuticals, Inc. (PDRX)
OTCMKTS
· Delayed Price · Currency is USD
2.760
+0.010 (0.36%)
At close: Apr 16, 2025
PD-Rx Pharmaceuticals Revenue
In the fiscal year ending June 30, 2024, PD-Rx Pharmaceuticals had annual revenue of $18.95M, down -10.93%. PD-Rx Pharmaceuticals had revenue of $1.60M in the quarter ending December 31, 1999, a decrease of -2.49%.
Revenue
18.95M
Revenue Growth
-9.89%
P/S Ratio
0.24
Revenue / Employee
676.66K
Employees
28
Market Cap
4.54M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 18.95M | -2.33M | -10.93% |
Jun 30, 2023 | 21.27M | -7.44M | -25.92% |
Jun 30, 2022 | 28.72M | 7.11M | 32.93% |
Jun 30, 2021 | 21.60M | 576.65K | 2.74% |
Jun 30, 2020 | 21.03M | 154.57K | 0.74% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SS Innovations International | 20.65M |
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Northwest Biotherapeutics | 1.38M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 200.90M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |